New Drugs Helps Hemophilia

Posted: Sep 4 2015, 5:13pm CDT | by , Updated: Sep 4 2015, 5:15pm CDT, in News | Latest Science News


New Drugs Helps Hemophilia
Photo Credit: Roche

There is some hope for people who suffer from hemophilia, a disease of the blood that leaves them susceptible to other problems. The pharmaceutical company Rouche announced that they have found a breakthrough $11 million treatment and have been approved by the US Food and Drug Administration for hemophilia treatment. Roche, which is based in Switzerland, said that Genetech, which is based in the US secured the fast track for a drug labelled ACE910, which will go into trial mode throughout this year and into 2016. The first trial will be for patients that have hemophilia A with factor VIII inhibitors and the next for patients without the inhibitors, according to The Times Gazette.

The new medication will be in direct opposition with those offered by Baxalta and Novo Nordisk. Baxalta is currently a target for a takeover of $30 billion by Shire.

Hemophilia A is a rare genetic disorder that prevents blood from clotting. Patients have to get blood clotting infusions to survive. However, sometimes patients aren't susceptible for treatment and their body interferes with it.

It is estimated that Hemophilia medications, which are very expensive, will make over $11 million in 2016. The ACE910 drug by Roche is being watched extremely closely by many because it could eventually change the way medical caregivers treat the disease.

Sandra Hornung, the chief medical officer at Roche, said that the FDA granted permission because they recognize that it meets a segment of the population that it hasn't met before.

Roche announced in 2014, that is reduced the rates of bleeding in the participants.

You May Like


The Author

<a href="/latest_stories/all/all/46" rel="author">Noel Diem</a>
Noel passion is to write about geek culture.




Leave a Comment

Share this Story

Follow Us
Follow I4U News on Twitter
Follow I4U News on Facebook

You Also Like


Read the Latest from I4U News